Tag:
GE Healthcare
Latest Headlines
Latest Headlines
FCC approves spectrum bandwidth for medical devices
GE Healthcare ($GE) and Philips Healthcare and their competitors got what they wanted from the Federal Communications Commission this week: A unanimous vote to allow spectrum bandwidth for medical devices.
Covidien, GE Healthcare to blend patient monitoring system tech
Covidien ($COV) and GE Healthcare are forming one of those trusty "global collaboration" deals, this time to expand production of beefed-up patient monitoring systems.
Top 10 Medical Device R&D Budgets
In the face of a sluggish economy barely recovering from its historic collapse in 2008, almost all of the companies made a concerted effort to boost their R&D spending during their 2011 fiscal years.
GE Healthcare, Japanese partner to pursue Alzheimer's Dx
GE Healthcare will join forces with a Japanese biotechnology venture in a bid to develop a different way to detect Alzheimer's disease in the brain at a very early stage.
GE touts good early data for Alzheimer's imaging Dx
GE Healthcare is taking up the baton in the bid to get an imaging agent approved that could help better diagnose Alzheimer's patients. It is touting positive early results from two Phase III studies of its imaging agent flutemetamol.
GE Healthcare grabs genomic sequencing CRO SeqWright
GE Healthcare continues its quest to grab more genomic sequencing business, this time by snatching up contract genomic researcher SeqWright.
GE Healthcare ups molecular diagnostics game
GE Healthcare is upping its game in a bid to develop new, targeted molecular diagnostics.
DiaGenic, GE combine genes and imaging for AD
The Norwegian company is uniting its expertise in peripheral gene expression profiling with GE Healthcare's PET imaging know-how.
GE Healthcare grabs Xcellerex to boost biomanufacturing prowess
GE Healthcare ($GE) is snatching up Xcellerex for an undisclosed price, another step in the company's plans to boost its position in biomanufacturing.
GE Healthcare moves further into biopharmaceutical field, buys Xcellerex
GE Healthcare is expanding its line of tools to sell to the biopharmaceutical industry.
